On July 18, 2026, the parallel forum on Brain-Computer Interface (BCI) titled "Smart Connected BCI, Data Aggregation in Hunan" for 2026, a featured sub-forum of the 3rd Central China Digital Economy Development Conference and the 6th Hunan Provincial Digital Industry Development Forum, successfully concluded in Changsha. Hangzhou NEUREAL Technology Co., Ltd. was invited to attend, sharing its innovative non-invasive psychiatric care technology roadmap integrating BCI and VR, along with scaled clinical implementation results, and exploring new paths for BCI medical industrialization with experts from academia, industry, and research across the nation.
The forum gathered representatives from BCI enterprises, university researchers, and clinical experts, among others. Through diverse sessions including cutting-edge technology presentations, supply-demand matching within the industry chain, physical product displays, open discussions, and public welfare project launches, it established an integrated platform for collaboration among industry, academia, research, and application in the BCI field, injecting strong momentum into the coordinated development of the central region's BCI intelligent industry.
Deep Integration of BCI and VR: Establishing a Full-Scenario Closed Loop for Psychiatric Care
During the expert presentation session, Professor Ma Ning, Research Director at NEUREAL, discussed the "Innovative Model of Psychiatric Care Integrating BCI and VR." Professor Ma pointed out that current diagnosis and treatment for mental disorders such as depression and autism still face challenges including low screening efficiency, limited intervention methods, and insufficient full-scenario coverage.
Leveraging brain circuit theory, the NEUREAL team deeply integrates immersive VR scenarios with EEG-based intervention technologies to create non-invasive, personalized diagnostic and treatment solutions for mental disorders. By using intelligent algorithms to optimize screening efficiency and enhance intervention effectiveness, multiple devices have been deployed in hundreds of hospitals nationwide. These solutions cover both clinical care and home rehabilitation scenarios, achieving a full-scenario intervention loop for mental disorders from hospital to home, providing a replicable paradigm for the implementation of digital therapeutics in psychiatry.
After the speech, NEUREAL’s exhibition area quickly became the focus of the event. The booth was crowded with industry peers consulting and experiencing the products. Many guests stayed for extended periods, engaging in in-depth discussions on clinical implementation details and technical pathways. Several authoritative industry experts also visited the exhibit to provide guidance, offering high praise for the products' clinical application value and technological innovation advantages.
Synergizing Industry, Academia, Research, and Medicine: Empowering Innovative Development of Digital Healthcare in Central China
Currently, China's BCI industry is in a critical window period characterized by accelerated technological iteration and scaled scenario implementation. While invasive BCIs primarily target the reconstruction of severe motor and visual functions, non-invasive BCIs bear the core mission of promoting mass brain health and accessible neuropsychiatric care. These two technological pathways are complementary and symbiotic, jointly constructing a complete closed loop for the domestic BCI industry.
As a benchmark enterprise in the fields of BCI and digital therapeutics, NEUREAL is actively translating this industry trend into regional implementation actions. Relying on the bridge for central regional industrial collaboration built by this forum, NEUREAL is leveraging synergies to support the innovative development of digital healthcare in central China, utilizing non-invasive BCI to empower universal access to brain health services.
